The current S1 guideline from the DGN and DMKG lists magnesium as a possible option for migraine prophylaxis. An evidence-based overview of what that means in concrete terms, what studies show about vitamin B2 and coenzyme Q10, and where the limits lie.
View Multi-Magnesium Bio-Complex →Summary
The current S1 guideline "Therapy of Migraine Attacks and Migraine Prophylaxis" by the DGN and DMKG (as of 2025) classifies magnesium (600 mg daily) as a possible, albeit only limitedly evidence-backed, prophylactic option. For vitamin B2 (riboflavin, 400 mg daily) and coenzyme Q10 (100–150 mg daily), there are individual placebo-controlled studies showing a reduction in migraine days or frequency, though the total number of studies is still manageable. None of these three micronutrients replaces a medical diagnosis or guideline-based migraine therapy—neurological evaluation is always advisable for frequent or changing headaches.
- Migraine briefly explained: More than just a headache
- What the current guideline says about micronutrients
- Trigger factors and lifestyle as the basis for any prophylaxis
- Magnesium for migraines: What studies show
- Vitamin B2 (riboflavin): The underrated option
- Coenzyme Q10: Effect on frequency and severity
- Combination: more than the sum of its parts?
- Expert Perspectives & Protocol Breakdown
- Comparing the three micronutrients
- Practical implementation
- Common myths about migraine and supplementation
- Who should be cautious – and when to see a doctor
- Frequently Asked Questions
Migraine briefly explained: More than just a headache
Migraine is a neurological condition, not a "severe headache attack" in the everyday sense. It is characterized by recurring, usually unilateral, pulsating or throbbing headaches of moderate to severe intensity that worsen with physical activity and are often accompanied by nausea, sensitivity to light, and sound. In about one in three affected individuals, the actual pain phase is preceded by an aura with temporary visual, speech, or sensory disturbances. It is estimated that about 10 to 15 percent of adults in Germany are affected by migraines; women are about three times more likely than men, with hormonal fluctuations considered a possible influencing factor.
Today, migraines are considered, among other things, a consequence of altered brain excitability and impaired stimulus processing in the trigeminal nerve system, which may also involve the energy supply of nerve cells (mitochondrial function). This is exactly where the three micronutrients discussed in this article come in: Magnesium, vitamin B2, and coenzyme Q10 are discussed in research primarily in the context of neuronal excitability and mitochondrial energy provision, not as traditional painkillers.
What the current guideline says about micronutrients
The S1 guideline "Therapy of Migraine Attacks and Migraine Prophylaxis" of the German Society of Neurology (DGN) and the German Migraine and Headache Society (DMKG), last updated in 2025, classifies magnesium in a dosage of 600 mg daily as a possible option for migraine prophylaxis. At the same time, the guideline explicitly emphasizes that the evidence base for magnesium, as well as for herbal preparations such as butterbur, is limited overall.
Therefore, the recommendation is not "magnesium is proven to be effective against migraine," but rather: individual patients who want to try a low-side-effect option should be able to do so—in consultation with their treating physician. For vitamin B2 and coenzyme Q10, there is no comparably prominent mention in the current German S1 guideline, but there is a series of smaller, partially placebo-controlled clinical studies referred to by societies for biofactors and individual neurological publications. These studies are generally smaller in scale than large drug approval trials, which limits their significance, but this is common in migraine research overall, as micronutrients are commercially less heavily researched than patentable active ingredients.
Important context: There is no EFSA-approved specific health claim for migraine prophylaxis for any of the three micronutrients discussed in this article. The effects described here originate from individual clinical studies, not from an officially confirmed efficacy statement. For magnesium, only the general statement "magnesium contributes to the normal functioning of the nervous system" is approved across the EU.
Trigger factors and lifestyle as the basis for any prophylaxis
Before magnesium, vitamin B2, or coenzyme Q10 even come into play, it is worth looking at the best-known migraine triggers, as the largest and best-documented levers often lie here. Commonly reported triggers include irregular or insufficient sleep, skipped meals with strongly fluctuating blood sugar, inadequate hydration, alcohol—especially red wine in sensitive individuals—major weather changes, and psychological stress; often, the relaxation phase after a stressful week can trigger an attack, a phenomenon known in headache medicine as "weekend migraine."
In women, the menstrual cycle also plays a documented role: the drop in estrogen levels shortly before menstruation is considered one of the most reliable triggers for menstrual migraine. A headache or migraine diary that tracks sleep, meals, hydration, stress levels, and, for women, the day of the cycle, remains one of the most effective and cost-free tools for identifying individual patterns, even before considering supplementation. Only once trigger avoidance and a stable daily rhythm have been exhausted, or if attacks continue to occur too frequently, does targeted micronutrient prophylaxis become a sensible next step for many sufferers.
Magnesium for migraines: What studies show
Magnesium is involved in several processes that may play a role in migraine, including the regulation of neuronal excitability and the dilation of blood vessels. Some studies suggest that people with migraines frequently exhibit lower magnesium levels in brain tissue or blood cells compared to those who do not have migraines, although this observation does not necessarily prove a causal relationship.
In clinical studies on migraine prophylaxis, 400 to 600 mg of elemental magnesium were mostly used daily, divided into one to two doses over a period of 8 to 12 weeks. The results are inconsistent: some placebo-controlled studies showed a significant reduction in the frequency and duration of migraine attacks, while other studies found no statistically significant difference compared to placebo. The DGN/DMKG guideline summarizes this overall situation as "limited evidence with good tolerability"—a reason why magnesium is nonetheless often used in practice as a low-side-effect first attempt before prescription prophylactics are considered.
A practically relevant limiting factor: Higher magnesium doses are not always reached in studies because magnesium can have a laxative effect from a certain amount. Magnesium citrate and bisglycinate are generally considered more tolerable for the gastrointestinal tract than magnesium oxide, which can improve the practical feasibility of higher-dosed, long-term intake. Individuals with impaired kidney function should generally seek medical advice before supplementing with magnesium at this dosage, as the kidneys cannot reliably excrete excess magnesium.
Vitamin B2 (riboflavin): The underrated option
Vitamin B2, also known as riboflavin, is a central building block of mitochondrial energy production—that is, the very process that may be impaired in the nerve cells during a migraine. In a placebo-controlled study by Jean Schoenen and colleagues, participants received 400 mg of riboflavin daily for three months; the result was an average 50 percent reduction in the frequency of migraine attacks in the riboflavin group compared to the placebo group. The group studied was, however, relatively small, with about 55 people, which is why larger follow-up studies would be desirable to confirm the results.
Riboflavin is considered very well-tolerated at the dosages used in studies; the most common reported side effect is a harmless, intense yellow discoloration of the urine due to the water-soluble excretion of excess vitamin. A relevant advantage over many prescription prophylactics is the resulting very low risk of side effects, which is why riboflavin is occasionally mentioned in neurological literature as an option for people who particularly want to avoid medication side effects or are looking for a well-tolerated supplement in addition to existing therapy.
Coenzyme Q10: Effect on frequency and severity
Coenzyme Q10 is a fat-soluble molecule produced by the body that is indispensable in the mitochondria for electron transport and thus for cellular energy production. In a randomized, placebo-controlled study by Peter S. Sándor and colleagues with episodic migraine, daily intake of 100 mg of coenzyme Q10 over three months led to a halving of migraine frequency in about 48 percent of participants, compared to a significantly smaller proportion in the placebo group. The number of days with nausea during attacks was also reduced in the coenzyme Q10 group.
In the underlying studies, dosages between 100 and 150 mg daily were used, divided into one to three doses, each for at least three months, as experience shows the effect builds up only after several weeks. Coenzyme Q10 is generally considered well-tolerated; mild gastrointestinal symptoms are occasionally reported. Since coenzyme Q10 can influence the effect of blood-thinning medications like Marcumar, intake should be coordinated with a doctor if anticoagulants are already being taken.
Combination: more than the sum of its parts?
Beyond individual effects, a fixed combination of all three micronutrients discussed here has also been studied. In a randomized, placebo-controlled, multicenter, double-blind study by Charly Gaul and colleagues with about 130 participants aged 18 to 65, one group received a combination supplement containing magnesium (600 mg), vitamin B2 (400 mg), and coenzyme Q10 over twelve weeks. The average number of migraine days per month decreased in the treatment group from 6.2 to 4.4 days, and migraine-related symptoms and quality of life improved compared to placebo. Regarding migraine frequency itself, however, the difference between the treatment and placebo groups reached only a statistical trend, not complete significance—an indication that the effect is real, but likely moderate and not equally strong in all affected individuals.
Important context: A separate, methodologically weaker open study by Hans-Christoph Diener and colleagues without a placebo group additionally investigated an expanded combination of magnesium, vitamin B2, feverfew, Andrographis paniculata, and coenzyme Q10 for episodic migraine.
Without a placebo control, however, it is not possible to reliably derive from such an open-label study which portion of the observed improvement is due to the supplementation itself and which is due to the known placebo or expectation effect. For a reliable assessment of the triple combination of magnesium, vitamin B2, and coenzyme Q10, the placebo-controlled study of 130 people by Gaul and colleagues remains the more meaningful source, even if further, larger follow-up studies would be desirable.
Expert Perspectives & Protocol Breakdown
Jean Schoenen (Université de Liège) and his team focused in their 1998 riboflavin study on a single micronutrient in an isolated, high dosage (400 mg) to cleanly separate its independent effect from other influencing factors. This reductionist approach provides a clear statement regarding riboflavin alone, but says little about how the effect behaves when multiple micronutrients are administered simultaneously.
Charly Gaul and his team pursued the opposite approach with the combination study published in 2015: They tested magnesium, vitamin B2, and coenzyme Q10 together as a fixed triple combination, closer to the way affected individuals would actually take a preparation in practice. The trade-off of this approach: one cannot derive from a combination study which of the three micronutrients has the greatest share in the observed effect—but it depicts the real-world application scenario more realistically than the single-substance studies. For readers, this comparison means: those seeking maximum certainty regarding a single substance will find it more in the single-substance studies by Schoenen or Sándor; those looking for a practice-oriented overall strategy will find more suitable guidance in the combination study by Gaul.
Comparing the three micronutrients
| Nutrient | Study Dosage | Strength of Evidence | Notes |
|---|---|---|---|
| Magnesium | 400–600 mg/day | Limited (according to DGN/DMKG guidelines) | Can have a laxative effect at high doses; consult a doctor beforehand if you have renal insufficiency |
| Vitamin B2 (Riboflavin) | 400 mg/day | Single study, small group (~55 people) | Harmless yellow urine discoloration possible; very good tolerance |
| Coenzyme Q10 | 100–150 mg/day | Randomized study, moderate group size | Can influence the effect of anticoagulants |
Practical Implementation
Those who wish to try a micronutrient-based migraine prophylaxis will benefit from a structured approach rather than random experimentation. It makes sense to first keep a migraine diary for four to eight weeks before starting supplementation in order to realistically assess the frequency, duration, and triggers of one's own attacks—only in this way can it be judged later whether a change has actually occurred. Since all three micronutrients take weeks to build up their effect, a minimum duration of use of eight to twelve weeks is realistic before an assessment of effectiveness makes sense.
For magnesium, it is advisable to start gradually with a lower dose, which is increased over one to two weeks, in order to avoid the laxative effect of higher individual doses. Taking it with a meal improves tolerability for many people. Vitamin B2 and coenzyme Q10 can be taken regardless of meals, although coenzyme Q10, as a fat-soluble molecule, tends to be absorbed slightly better when taken with a fatty meal.
It is important to consult a physician, especially if medicinal migraine prophylaxis or acute therapy is already in place. In neurological practice, micronutrients are generally discussed as a possible supplement, not as a replacement for existing treatment.
For whom is this approach suitable at all? Most likely for people with episodic migraine, i.e., up to about 14 headache days per month, who would like to try a low-side-effect, well-tolerated option before or alongside drug therapy. Those who already frequently use acute medications such as triptans and are concerned about medication-overuse headache will find magnesium, vitamin B2, and coenzyme Q10 to be an option with a comparatively low risk profile. A purely micronutrient-based approach is less suitable for people with chronic migraine or very frequent, severely debilitating attacks—in these cases, a structured, medically supervised prophylaxis is generally required, to which micronutrients can at best contribute as a complementary building block.
Common Myths about Migraine and Nutritional Supplements
Myth 1: "Magnesium cures migraine." According to the current state of research, this is not true. At best, magnesium can reduce the frequency or severity of attacks in some affected individuals—none of the available studies describe a cure in the sense of the condition disappearing completely.
Myth 2: "Migraine is just a particularly strong headache attack." Migraine is an independent neurological disease with a specific symptom profile and its own pathophysiology; it is not a more severe form of tension headache.
Myth 3: "Those taking nutritional supplements don't need a medical check-up." Especially with new, changing, or unusually frequent headaches, a medical examination is important to rule out other causes. Micronutrients are a possible supplement, not a replacement for diagnostics.
Myth 4: "Higher doses automatically work better." For none of the three micronutrients do studies show a linear relationship between dose and effect above the quantities examined. Overdosing on magnesium can also cause unwanted effects such as diarrhea or, in rare cases of severely impaired kidney function, more serious complications.
Who should be cautious—and when to see a doctor
Regardless of any nutritional supplements, a doctor's visit is urgently indicated in the case of suddenly occurring, extremely severe headaches ("thunderclap headache"), headaches with fever, neck stiffness, confusion, or neurological deficits, the first occurrence of migraine with aura after the age of 40, as well as a noticeable change in the usual headache pattern. These signs may point to more serious causes and require timely medical clarification instead of self-treatment.
People with impaired kidney function should only take higher doses of magnesium after consulting a doctor. Those taking anticoagulant medications such as Marcumar or phenprocoumon should check with a doctor regarding coenzyme Q10 beforehand. Pregnant and breastfeeding women should generally discuss any new, higher-dose nutritional supplements beforehand. People with chronic migraine (15 or more days per month) generally require guideline-compliant medical prophylaxis, where micronutrients can at most play a complementary role.
You can find more on the individual nutrients in our study checks on Magnesium for muscles, sleep, and stress and on Coenzyme Q10 and health risks.
Frequently Asked Questions
Does magnesium really help with migraine?
The DGN/DMKG guidelines list magnesium (600 mg daily) as a possible option, but emphasize limited evidence. Individual studies show a reduction in the frequency and duration of attacks, while others show no significant effect.
How quickly does vitamin B2 or coenzyme Q10 work for migraine?
In the studies, the effect was assessed after at least eight to twelve weeks of continuous intake. An immediate effect during acute attacks is not to be expected.
Can I combine magnesium, vitamin B2, and coenzyme Q10?
Yes, a placebo-controlled study by Gaul and colleagues with about 130 participants tested this exact triple combination and showed a reduction in migraine days as well as improved quality of life. Regarding migraine frequency itself, the difference compared to the placebo was only a statistical trend.
Do these micronutrients replace medical migraine therapy?
No. At best, they are considered a possible supplement. In cases of frequent, severe, or changing migraines, medical or neurological evaluation and therapy are important.
What side effects can occur?
In higher doses, magnesium can have a laxative effect. Vitamin B2 can harmlessly color urine yellow. Coenzyme Q10 can occasionally cause mild gastrointestinal issues and affect the efficacy of anticoagulants.
Who should definitely ask a doctor before taking them?
People with impaired kidney function (magnesium), those on anticoagulant medication (coenzyme Q10), pregnant and breastfeeding women, as well as people with chronic migraines or new, unusual headaches.
Is there an approved health claim for migraines?
No. For none of these three micronutrients does an EFSA-approved claim exist specifically for migraine prophylaxis. For magnesium, only the general claim regarding the normal function of the nervous system is approved.
What are the most important everyday migraine triggers?
The most common triggers include irregular sleep, skipped meals, insufficient fluid intake, alcohol, stress or the relaxation phase afterward, weather changes, and, in women, the drop in hormones before menstruation. A migraine diary helps in identifying individual patterns.
Targeted support for the nervous system & cellular energy
Multi-Magnesium Bio-Complex and Coenzyme Q10 200mg, lab-tested and made in Germany.
Discover products →Lab-tested and free from unnecessary additives. GDPR-compliant shipping within Germany, secure payment via PayPal, Klarna, and credit card, transparent return policy.
References & Scientific Citations
- DGN/DMKG. S1 Guideline on the Treatment of Migraine Attacks and Migraine Prophylaxis, AWMF Register No. 030-057 (2025)
- Schoenen et al. (1998). Effectiveness of High-Dose Riboflavin in Migraine Prophylaxis: A Randomized Controlled Trial, Neurology
- Sándor et al. (2005). Efficacy of Coenzyme Q10 in Migraine Prophylaxis: A Randomized Controlled Trial, Neurology
- Gaul et al. (2015). Improvement of Migraine Symptoms with a Proprietary Supplement Containing Riboflavin, Magnesium and Q10, The Journal of Headache and Pain
- Diener et al. (2021). Open-Label Study on a Fixed Combination of Magnesium, Riboflavin, Feverfew, Andrographis Paniculata and Coenzyme Q10 in Episodic Migraine, Journal of Clinical Medicine
- European Commission, Regulation (EU) No 432/2012, approved health claim regarding magnesium and the nervous system.
- Gesellschaft für Biofaktoren e.V.
This article is for general information purposes and does not replace medical diagnosis or treatment.
